H. Anne Pereira, Ph.D.

David L. Boren Professor/Dean, Graduate College

Pharmaceutical Sciences

Phone (405) 271-6593 x58034

Fax (405) 271-7505

Office CPB 329

Email anne-pereira@ouhsc.edu


Summary

My laboratory investigates the role of a novel inflammatory mediator known as CAP37. We focus on the significance of this protein in host defense against severe infections including infections of the eye and in various inflammatory mediated diseases such as atherosclerosis and Alzheimer's disease. We currently employ a combination of cellular, immunological, biochemical and molecular approaches at the in vitro and in vivo level to solve these questions. Our long-term goals are to design new and effective antibiotics and anti-inflammatory therapeutics.



Research

This laboratory investigates the role of a novel inflammatory mediator known as CAP37. We focus on the significance of this protein in host defense against severe infections including infections of the eye and in various inflammatory mediated diseases such as atherosclerosis and Alzheimer's disease. We currently employ a combination of cellular, immunological, biochemical and molecular approaches at the in vitro and in vivo level to solve these questions. Our long-term goals are to design new and effective antibiotics and anti-inflammatory therapeutics.



Patents

Biomarker and method for detecting a chronic inflammatory-associated disease

Patent No. 8,450,071

USA

H. Anne Pereira



Publications & Presentations

<< 4 5 6 7 8 9 10 > >>
    31. Brackett D J, Lerner M R, Lacquement M A, He R, Pereira H A. A synthetic lipopolysaccharide-binding peptide based on the neutrophil-derived protein CAP37 prevents endotoxin-induced responses in conscious rats. Infection and immunity. 1997; 65 : 2803-11

    32. Pereira H A. Assay systems for measurement of chemotactic activity. Methods in molecular biology (Clifton, N.J.). 1997; 78 : 233-46

    33. Brackett D J, Lerner M R, Pereira H A. Neutralization of the in vivo activity of E. coli-derived lipopolysaccharide by cationic peptides. Methods in molecular biology (Clifton, N.J.). 1997; 78 : 247-55

    34. Pereira H A, Moore P, Grammas P. CAP37, a neutrophil granule-derived protein stimulates protein kinase C activity in endothelial cells. Journal of leukocyte biology. 1996; 60 : 415-22

    35. Aragon A S, Pereira H A, Baca O G. A cationic antimicrobial peptide enhances the infectivity of Coxiella burnetii. Acta virologica. 1995; 39 : 223-226

<< 4 5 6 7 8 9 10 > >>



Grants

<< 1 2 3 4 5 >>
    16. Molecular Basis of Immunity. NIH. Start Date: 2012. End Date: 2017.

    17. Novel topical peptide therapeutic for the treatment of wounds infected with antibiotic resistant Gram negative bacteria. Non-federal. Start Date: 2016. End Date: 2017.

    18. Wound healing mechanisms modulated by novel antimicrobial peptide. Misc Non-Federal. Start Date: 2015. End Date: 2016.

    19. 48th Annual Meeting of the Society for leukocyte Biology - Immunity in Health and Disease. NIH. Start Date: 2015. End Date: 2016.

    20. Role of CAP37 in Neuroinflammation: Friend or Foe?. State Agency. Start Date: 2012. End Date: 2015.

<< 1 2 3 4 5 >>



Awards and Honors

<< 1 2 3 4
                                                                                            16. Commonwealth of Australia. Commonwealth Postgraduate Research Award. Date: 1977.  

<< 1 2 3 4



Education

                                                                                            1.  Degree: Ph D. University of Melbourne. Date: 1982.  

                                                                                            2.  Degree: BSc (Honours) First class honours & First Place. University of Melbourne. Date: 1976.  

                                                                                            3.  Degree: BS. University of Melbourne. Date: 1975.